<DOC>
	<DOCNO>NCT01450761</DOCNO>
	<brief_summary>The purpose study determine whether addition Ipilimumab Etoposide Platinum therapy extend live patient Extensive-Stage Disease Small Cell Lung Cancer ( ED-SCLC ) Etoposide Platinum therapy alone .</brief_summary>
	<brief_title>Trial Extensive-Disease Small Cell Lung Cancer ( ED-SCLC ) Subjects Comparing Ipilimumab Plus Etoposide Platinum Therapy Etoposide Platinum Therapy Alone</brief_title>
	<detailed_description />
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . ExtensiveStage Disease Small Cell Lung Cancer ( EDSCLC ) Eastern Cooperative Oncology Group ( ECOG ) 0 1 Prior systemic therapy lung cancer Symptomatic Central Nervous System ( CNS ) metastases History autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>